The journey from academic 'eureka' to commercial patent is broken. We dissect the hidden costs of **technology transfer** and **intellectual property** management.
.jpg&w=3840&q=75)
The sudden focus on Pacific Northwest National Laboratory (PNNL) for a Trump AI initiative isn't about science—it's about control over the next industrial revolution.
Forget better models. Agentic AI is a systemic shift that threatens to automate experimentation itself, making mid-level data science obsolete.
The recent Majorana qubit decoding is a watershed moment in quantum computing, but the real story is who controls the roadmap.
The NIDHC Summit touted breakthroughs, but the real story in **technology** and **innovation** is who controls the pipeline.
The narrative of 'science accelerated' masks a dangerous consolidation of power. Unpacking the true winners and losers in today's breakneck scientific progress.
Dr. Anita Bandrowski's APE Award signals a seismic shift in **scholarly communication** and **research integrity**. But who really benefits from this push for **transparency**?
The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.
The recent US patent for TrialAssure's date offset technology reveals a deeper struggle over clinical trial data integrity and ownership.
Five years after its breakthrough, the true cost of AlphaFold's AI revolution in **protein folding** is emerging. It's not just about science.
AI is boosting neuroprotective drug trials for stroke, but who truly profits from this precision medicine revolution? The real battle is over data ownership.
DP Technology's massive Series C signals a chilling trend: the consolidation of scientific data, not just the acceleration of breakthroughs.